Study reveals predictor of early mortality in AMLNovember 28, 2017Leukemia, Myelodysplasia, TransplantationAML
How CLL patients weigh treatment efficacy, safety, and costNovember 26, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
CCSs have increased risk of hypertensionNovember 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Method identifies effective treatments for leukemias, lymphomasNovember 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLNon-Hodgkin LymphomaAggressive Lymphomas
PTSD can persist in cancer survivorsNovember 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Nilotinib approved to treat kids with CML in EUNovember 21, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
CD22-CAR therapy shows activity in rel/ref B-ALLNovember 21, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
Team discovers mechanism of resistance in AMLNovember 18, 2017Leukemia, Myelodysplasia, TransplantationAML
Rigosertib produces better OS in MDS than tAMLNovember 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
FDA approves generic clofarabineNovember 16, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Generic azacitidine approved in CanadaNovember 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationPharmacyAMLMyelodysplastic Syndrome
Parity laws don’t lower oral cancer drug costs for everyoneNovember 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Dasatinib approved to treat kids with CMLNovember 11, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
FDA approves IV formulation of aprepitant for CINVNovember 10, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
EMA grants accelerated assessment to drug for AMLNovember 9, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML